Targeting innate immunity-driven inflammation in CKD and cardiovascular disease

T Speer, S Dimmeler, SJ Schunk, D Fliser… - Nature Reviews …, 2022 - nature.com
Mortality among patients with chronic kidney disease (CKD) is largely a consequence of
cardiovascular disease (CVD) and is a particular concern given the increasing prevalence of …

[HTML][HTML] Treatment of diabetic kidney disease: current and future

T Yamazaki, I Mimura, T Tanaka… - Diabetes & metabolism …, 2021 - ncbi.nlm.nih.gov
Diabetic kidney disease (DKD) is the major cause of end-stage kidney disease. However,
only renin-angiotensin system inhibitor with multidisciplinary treatments is effective for DKD …

Punicalagin protects diabetic nephropathy by inhibiting pyroptosis based on TXNIP/NLRP3 pathway

X An, Y Zhang, Y Cao, J Chen, H Qin, L Yang - Nutrients, 2020 - mdpi.com
Diabetic nephropathy is a diabetic complication caused by chronic inflammation. As the
primary polyphenol in pomegranate, punicalagin is believed to have significant anti …

[HTML][HTML] Epigenetic regulation of TXNIP-mediated oxidative stress and NLRP3 inflammasome activation contributes to SAHH inhibition-aggravated diabetic …

X Dai, R Liao, C Liu, S Liu, H Huang, J Liu, T Jin… - Redox biology, 2021 - Elsevier
S-adenosylhomocysteine (SAH) is hydrolyzed by SAH hydrolase (SAHH) to homocysteine
and adenosine. Increased plasma SAH levels were associated with disturbed renal function …

New insights into the mechanisms of pyroptosis and implications for diabetic kidney disease

J Lin, A Cheng, K Cheng, Q Deng, S Zhang… - International journal of …, 2020 - mdpi.com
Pyroptosis is one special type of lytic programmed cell death, featured in cell swelling,
rupture, secretion of cell contents and remarkable proinflammation effect. In the process of …

Thioredoxin-interacting protein (TXNIP) with focus on brain and neurodegenerative diseases

H Tsubaki, I Tooyama, DG Walker - International journal of molecular …, 2020 - mdpi.com
The development of new therapeutic approaches to diseases relies on the identification of
key molecular targets involved in amplifying disease processes. One such molecule is …

Role of thioredoxin-interacting protein in diseases and its therapeutic outlook

N Qayyum, M Haseeb, MS Kim, S Choi - International Journal of …, 2021 - mdpi.com
Thioredoxin-interacting protein (TXNIP), widely known as thioredoxin-binding protein 2
(TBP2), is a major binding mediator in the thioredoxin (TXN) antioxidant system, which …

TXNIP in metabolic regulation: physiological role and therapeutic outlook

N Mohammad Alhawiti, S Al Mahri… - Current drug …, 2017 - ingentaconnect.com
Background & Objective: Thioredoxin-interacting protein (TXNIP) also known as thioredoxin
binding protein-2 is a ubiquitously expressed protein that interacts and negatively regulates …

NLRP3 deficiency ameliorates renal inflammation and fibrosis in diabetic mice

M Wu, W Han, S Song, Y Du, C Liu, N Chen… - Molecular and cellular …, 2018 - Elsevier
Diabetic nephropathy (DN) is the leading cause of end-stage renal disease. Activation of the
nucleotide binding and oligomerization domain-like receptor family pyrin domain-containing …

Epigenomic profiling reveals an association between persistence of DNA methylation and metabolic memory in the DCCT/EDIC type 1 diabetes cohort

Z Chen, F Miao, AD Paterson… - Proceedings of the …, 2016 - National Acad Sciences
We examined whether persistence of epigenetic DNA methylation (DNA-me) alterations at
specific loci over two different time points in people with diabetes are associated with …